Degarelix Before Radical Prostatectomy
NCT01852864
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
240mg degarelix s.c. injection
Sponsor
University of Cambridge